OL
MIRM icon

Odyssean LLC’s Mirum Pharmaceuticals MIRM Stock Holding History

Odyssean LLC’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.5M Buy
29,924
+17,952
+150% +$1.8M 0.57% 8
2026
Q1 		$1.11M Buy
11,972
+2,695
+29% +$254K 0.4% 102
2025
Q4 		$733K Buy
+9,277
New +$666K 0.53% 100

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Odyssean LLC's MIRM Position: Q2 2026 in Review

Odyssean LLC increased its Mirum Pharmaceuticals (MIRM) stake by 150% in Q2 2026, buying an estimated $1.8M and bringing the position to 29,924 shares worth $3.5M. The position accounts for 0.57% of the portfolio, ranked #8.

Odyssean LLC first reported a position in MIRM in Q4 2025 and has held it in 3 quarters since. 326 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Odyssean LLC held 29,924 shares of Mirum Pharmaceuticals worth $3.5M as of Q2 2026.
  • Odyssean LLC bought 17,952 Mirum Pharmaceuticals shares in Q2 2026, an estimated $1.8M.
  • Mirum Pharmaceuticals made up 0.57% of Odyssean LLC's portfolio in Q2 2026, its #8 holding.
  • Odyssean LLC first reported a position in Mirum Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 326 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Odyssean LLC's 13F filing for Q2 2026, filed 14 Aug 2026.